Kyle C. Roche
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 2
- CAR-T cell therapy research 2
- Lung Cancer Research Studies 2
- Pancreatic and Hepatic Oncology Research 2
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Andrew Z. Wang (14 shared papers)Benjamin G. Vincent (4 shared papers)Jonathan S. Serody (4 shared papers)Yuanzeng Min (7 shared papers)Joseph M. Caster (6 shared papers)Joel E. Tepper (4 shared papers)Tian Zhang (3 shared papers)Longzhen Zhang (3 shared papers)
- Journals
- Nanomedicine Nanotechnology Biology and Medicine (2 papers)Gastroenterology (2 papers)Advanced Materials (2 papers)Biomaterials (2 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesChinaBrazil
In The Last Decade
Kyle C. Roche
20 papers receiving 1.6k citations
Kyle C. Roche's Hit Papers
Peers
Comparison fields: 5 of 90
- Biomaterials 412
- Immunology 556
- Oncology 526
- Biomedical Engineering 844
- Biotechnology 73
Countries citing papers authored by Kyle C. Roche
This map shows the geographic impact of Kyle C. Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle C. Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle C. Roche more than expected).
Fields of papers citing papers by Kyle C. Roche
This network shows the impact of papers produced by Kyle C. Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle C. Roche. The network helps show where Kyle C. Roche may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle C. Roche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy Hit paper breakdown → | 2017 | 615 |
| 2 | 2018 | 182 | |
| 3 | 2015 | 130 | |
| 4 | 2015 | 120 | |
| 5 | 2017 | 95 | |
| 6 | 2018 | 86 | |
| 7 | 2020 | 78 | |
| 8 | 2018 | 76 | |
| 9 | 2016 | 74 | |
| 10 | 2021 | 57 | |
| 11 | 2017 | 54 | |
| 12 | 2016 | 25 | |
| 13 | 2023 | 16 | |
| 14 | 2023 | 14 | |
| 15 | 2020 | 7 | |
| 16 | 2018 | 5 | |
| 17 | 2023 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2015 | 1 |
About Kyle C. Roche
Kyle C. Roche is a scholar working on Oncology, Immunology, Biomedical Engineering, Biomaterials and Molecular Biology, having authored 22 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Nanoplatforms for cancer theranostics (5 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (2 papers), Lung Cancer Research Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Biomaterials (412 citations), Immunology (556 citations), Oncology (526 citations), Biomedical Engineering (844 citations) and Biotechnology (73 citations). Kyle C. Roche has collaborated with scholars based in United States, China and Brazil. Frequent co-authors include Andrew Z. Wang, Benjamin G. Vincent, Jonathan S. Serody, Yuanzeng Min, Joseph M. Caster, Joel E. Tepper, Tian Zhang, Longzhen Zhang, Laura E. Herring and Joseph M. DeSimone. Their work appears in journals such as Nanomedicine Nanotechnology Biology and Medicine, Gastroenterology, Advanced Materials, Biomaterials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.